Physiogenex will be presenting a hyperinsulinemic euglycemic clamp study differentiating insulin analogues in STZ-rats, a model of experimental diabetes.
The study will be presented by Dr. François Briand, Director of Research and Business Development, during the poster session 1, on Monday October the 8th, poster #1012.

If you wish to make an appointment during the meeting with Dr. François Briand to discuss about your drug development project, please contact us.